Trial Profile
Relation of Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2013
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Pharmacogenomic; Therapeutic Use
- 15 Mar 2011 New trial record